These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7009138)

  • 1. Drug interactions with phenytoin.
    Perucca E; Richens A
    Drugs; 1981 Feb; 21(2):120-37. PubMed ID: 7009138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic drug interactions with phenytoin (Part I).
    Nation RL; Evans AM; Milne RW
    Clin Pharmacokinet; 1990 Jan; 18(1):37-60. PubMed ID: 2178849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions with antiepileptic drugs.
    Perucca E
    Clin Pharmacokinet; 1982; 7(1):57-84. PubMed ID: 7042173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic drug interactions with oral contraceptives.
    Back DJ; Orme ML
    Clin Pharmacokinet; 1990 Jun; 18(6):472-84. PubMed ID: 2191822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of anticonvulsants.
    Hvidberg EF; Dam M
    Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions and clinical pharmacokinetics.
    Kristensen MB
    Clin Pharmacokinet; 1976; 1(5):351-72. PubMed ID: 797504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
    Perucca E
    Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin does not affect the intestinal absorption of phenytoin in rat duodeno-jejunal loops in situ.
    Tonini M; Gatti G; Manzo L; Olibet G; Coccini T; Perucca E
    Pharmacol Res; 1992 Sep; 26(2):201-5. PubMed ID: 1409260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic drugs. A review of clinically significant drug interactions.
    Patsalos PN; Duncan JS
    Drug Saf; 1993 Sep; 9(3):156-84. PubMed ID: 8240723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.
    Spina E; Pisani F; Perucca E
    Clin Pharmacokinet; 1996 Sep; 31(3):198-214. PubMed ID: 8877250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin is dead, long live phenytoin?
    Brigo F
    Epilepsy Behav; 2012 May; 24(1):152. PubMed ID: 22481039
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid interactions.
    Baciewicz AM; Self TH
    South Med J; 1985 Jun; 78(6):714-8. PubMed ID: 3890202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients.
    Chiba K; Ishizaki T; Miura H; Minagawa K
    Pediatr Pharmacol (New York); 1980; 1(2):171-80. PubMed ID: 7346739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.
    Miners JO
    Clin Pharmacokinet; 1989 Nov; 17(5):327-44. PubMed ID: 2573442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug interactions between glucocorticoids and other drugs].
    Kawai S; Ichikawa Y
    Nihon Rinsho; 1994 Mar; 52(3):773-8. PubMed ID: 8164381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of phenytoin.
    Richens A
    Clin Pharmacokinet; 1979; 4(3):153-69. PubMed ID: 383353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between anticonvulsants.
    Lander CM; Eadie MJ; Tyrer JH
    Proc Aust Assoc Neurol; 1975; 12():111-6. PubMed ID: 2912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin-phenytoin interaction: re-evaluation using metabolite data.
    Rowland M; Gupta SK
    Br J Clin Pharmacol; 1987 Sep; 24(3):329-34. PubMed ID: 3663449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.
    Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
    J Pharm Pharmacol; 2003 Jan; 55(1):143-9. PubMed ID: 12625878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.